Basilea Pharmaceutica AG (LON:0QNA)

Basilea Pharmaceutica AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 23, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	628	442	394	490	393	475
Market Cap Growth	45.19%	12.05%	-19.52%	24.78%	-17.40%	21.19%
Enterprise Value	599	485	471	571	447	548
Last Close Price	51.14	36.45	33.42	41.15	33.38	44.00
PE Ratio	9.42	6.46	40.47	44.94	-	-
PS Ratio	2.90	2.40	2.68	3.69	3.27	4.50
PB Ratio	6.64	6.19	-42.28	-26.35	-8.27	-5.63
P/TBV Ratio	6.66	6.22	-	-	-	-
P/FCF Ratio	8.79	6.90	31.48	139.32	-	-
P/OCF Ratio	8.61	6.74	29.69	77.36	-	-
EV/Sales Ratio	2.70	2.64	3.20	4.31	3.72	5.19
EV/EBITDA Ratio	7.96	8.72	21.78	29.31	154.82	-
EV/EBIT Ratio	8.33	8.93	23.05	30.58	183.33	-
EV/FCF Ratio	8.37	7.58	37.59	162.43	-	-
Debt / Equity Ratio	0.94	1.38	-12.86	-9.03	-3.74	-2.37
Debt / EBITDA Ratio	1.21	1.71	5.05	7.76	41.61	-
Debt / FCF Ratio	1.24	1.54	9.57	47.76	-	-
Asset Turnover	1.08	0.97	0.80	0.63	0.62	0.57
Inventory Turnover	4.69	3.99	4.13	4.18	5.33	6.11
Quick Ratio	5.40	3.93	2.48	1.96	1.22	3.87
Current Ratio	6.32	4.85	3.20	2.34	1.38	4.46
Return on Equity (ROE)	121.15%	218.58%	-	-	-	-
Return on Assets (ROA)	21.88%	17.89%	6.95%	5.56%	0.79%	-5.93%
Return on Capital (ROIC)	29.07%	24.78%	9.61%	7.96%	1.25%	-10.88%
Return on Capital Employed (ROCE)	35.70%	29.10%	17.40%	14.30%	4.10%	-11.90%
Earnings Yield	10.61%	15.48%	2.47%	2.23%	-1.41%	-2.56%
FCF Yield	11.38%	14.50%	3.18%	0.72%	-6.73%	-9.74%
Buyback Yield / Dilution	-15.14%	-14.10%	-1.67%	-2.24%	-13.62%	4.41%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.